Medtronic(US:MDT) ZACKS·2025-06-30 22:51Company Performance - Medtronic's stock increased by 1.34% to $87.17, outperforming the S&P 500's gain of 0.52% [1] - Over the past month, Medtronic's stock has risen by 3.66%, while the Medical sector gained 1.88% and the S&P 500 increased by 4.27% [1] Upcoming Earnings - Medtronic's earnings report is expected on August 19, 2025, with an anticipated EPS of $1.23, indicating no change from the same quarter last year [2] - Revenue is projected to be $8.37 billion, reflecting a 5.69% increase compared to the same quarter last year [2] Fiscal Year Projections - For the entire fiscal year, earnings are projected at $5.55 per share and revenue at $35.29 billion, representing increases of 1.09% and 5.23% respectively from the prior year [3] Analyst Forecasts - Recent revisions to analyst forecasts for Medtronic should be monitored, as they reflect short-term business trends [4] - Positive estimate revisions are interpreted as a favorable sign for the business outlook [4] Zacks Rank and Valuation - The Zacks Rank system currently rates Medtronic as 5 (Strong Sell), with a 0% increase in the EPS estimate over the last 30 days [6] - Medtronic has a Forward P/E ratio of 15.51, which is lower than the industry average of 19.12 [7] - The company has a PEG ratio of 2.32, compared to the industry average PEG ratio of 2.25 [7] Industry Context - The Medical - Products industry has a Zacks Industry Rank of 155, placing it in the bottom 37% of over 250 industries [8] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [8]